Healthcare | Corporate Finance Advisory

BioLok Acquired by Healthpoint Capital

  • BioLok International Inc. (OTC) manufactures and distributes products that merge cell biology and technology to develop and market products for the dental implant and tissue regeneration markets
  • Healthpoint Capital (HPC) is a private equity firm exclusively focused on the orthopedic and dental device businesses
  • The Board of Directors of BioLok retained TM Capital to evaluate HPC’s proposed tender offer of $2.15 per share in cash, or $35 million, to acquire 100% of the outstanding shares of the company
  • TM Capital analyzed the transaction and rendered a fairness opinion to BioLok’s Board of Directors which was included in the company’s shareholder documents and public filings

See press Release

Client Testimonial